VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?Markus Albertsmeier(Ludwig-Maximilians-Universität München), Thomas Knösel(Ludwig-Maximilians-Universität München)CancersFebruary 16, 202210.3390/cancers14041006Cited by 6SaveCiteExport RISWatch citationsRelated PapersImmune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia|Endocrine Related Cancer|2019|83TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)|Cancers|2023|4